Lewy Body Dementia clinical trials at UCSD
3 research studies open to eligible people
RewinD-LB - Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies
open to eligible people ages 55 years and up
The purpose of this study is to determine whether neflamapimod can improve learning skills, problem solving skills, and memory loss in people diagnosed with DLB. More specifically, improvement in verbal learning, memory, and attention, as well as cognitive and functional performance will be measured.
La Jolla, California and other locations
Diagnostic Test for Dementia With Lewy Bodies
open to eligible people ages 50-85
The Syn-D Study will be evaluating α-synuclein in patients with suspected MCI-AD and MCI-DLB. Using a simple diagnostic test will improve clinical accuracy in diagnosing, earlier diagnosis, and distinguish between neurodegenerative diseases.
La Jolla, California and other locations
Environmental and Reproductive Health Risk for Lewy Body Dementia
open to eligible people ages 18 years and up
The goal of this survey study is to identify environmental, occupational and reproductive health risk factors for Lewy body dementia, which includes Parkinson's disease dementia and dementia with Lewy bodies. Participants will complete a one-time survey online or over the phone that includes questions on environmental, occupational factors they may have been exposed to and on medical history including reproductive health. Researchers will then compare the responses of people with Lewy body dementia and people without Parkinson's or memory/thinking problems to see which factors play a role in Lewy body dementia. Identifying risk factors can guide future treatment efforts and provide more insight to this dementia.
La Jolla, California
Our lead scientists for Lewy Body Dementia research studies include David Coughlin, MD Irene Litvan, MD Ece Bayram, MD, PhD.
Last updated: